Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

Clin Lab Haematol. 2004 Aug;26(4):291-3. doi: 10.1111/j.1365-2257.2004.00612.x.

Abstract

A 34-year-old woman with non-Hodgkin's lymphoma received high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT). She developed Evans' syndrome, the association of immune thrombocytopenia and autoimmune hemolytic anemia, 49 days after transplantation. Multiple autoimmune disorders may occur concurrently after autologous PBSCT.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Hemolytic, Autoimmune / drug therapy
  • Anemia, Hemolytic, Autoimmune / etiology*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / therapy*
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy
  • Purpura, Thrombocytopenic, Idiopathic / etiology*
  • Recurrence
  • Remission Induction
  • Syndrome
  • Transplantation, Autologous